Cannabis Company News

Tokyo Smoke Ignites Cannabis Investor Interest

Tokyo Smoke raises $3 million in Series A funding TORONTO, ON–(Marketwired – January 17, 2017) – Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has become the first Canadian cannabis...
- January 17th, 2017 at 3:05 pm

Kiva Expands Offerings and Prepares for California Legalization

Cannaly, which helps cannabis brands connect with dispensaries and streamline their ordering process, has begun profiling some of its customers. It recently interviewed Kiva Confections Marketing Communications Manager Christie...
- January 16th, 2017 at 11:37 am

Aurora Cannabis Added More than 12,000 Patients in 2016

Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales VANCOUVER, Jan. 16, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV:...
- January 16th, 2017 at 9:01 am

Aphria Approves $137mm Expansion Project

Aphria’s Vision to be Reality – Part IV expansion project to increase greenhouse growing space to 1 million square feet Project necessary to support continued mid-term demand expectations LEAMINGTON,...
- January 16th, 2017 at 8:40 am

Canopy Growth Pays $6.6mm to Buy 42-Acre Tweed Site

Canopy Growth Triples Tweed’s Production Potential by Acquiring 1 Hershey Drive SMITHS FALLS, ON, Jan. 16, 2017 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: CGC)...
- January 16th, 2017 at 8:00 am

Organigram Makes Key Hire to Advance Oils and Extracts Division

MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 13, 2017) – Licensed medical marijuana producer Organigram Holdings Inc. (“Organigram” or the “Company”) (TSXV: OGI) (OTCQ: OGRMF) is pleased to announce the addition of...
- January 13th, 2017 at 7:49 am

Therapix Extends Ultra-Low Dose Cannabinoid Development Program

Therapix Biosciences Provides Portfolio Update TEL AVIV, Israel, January 11, 2017 /PRNewswire/ — Therapix Biosciences (OTCQB: THXBY) (TASE: THXBY.TA), a clinical-stage pharma company specializing in the development of cannabinoid-based...
- January 12th, 2017 at 2:56 pm

Canopy Growth Gets First U.S. Investment Bank Coverage

Following up on its September initiation of coverage of the cannabis industry, Cowen and Company has extended its coverage to Canada in a report entitled “O Cannabis! – Initiating...
- January 10th, 2017 at 10:42 am

Aphria to Invest in New Cannabis Investment Fund

Green Acre Capital Launches Investment Fund Green Acre Capital Fund to Invest Exclusively in the Legal Cannabis Industry TORONTO, Jan. 9, 2017 /CNW/ – Green Acre Capital (“GAC”) is...
- January 9th, 2017 at 8:29 am

Emblem to Raise $10mm

Emblem Corp. (TSXV: EMC) (OTC: EMMBF) announced that PI Financial will lead a group of underwriters in a bought deal. The company will be selling 2,754,821 Special Warrants for...
- January 5th, 2017 at 4:47 pm

Canopy Growth Addresses Mettrum Recall Issue

Canopy Growth Corporation Comments on the Year that was 2016 SMITHS FALLS, ON, Jan. 3, 2017 /CNW/ – As a leader in Canada’s medical cannabis industry, Canopy Growth Corporation...
- January 3rd, 2017 at 1:04 pm

OrganiGram Announces Voluntary Product Recall

MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 30, 2016) – Licensed medical marijuana producer Organigram Holdings Inc. (TSX VENTURE: OGI) (OTC: OGRMF) (“Organigram” or the “Company”) is voluntarily recalling certain lots...
- December 30th, 2016 at 4:25 pm

CanniMed Deal a Dud as Cannabis IPO Tanks Initially

Early trading in CanniMed Therapeutics (TSX: CMED) was disappointing, as the recent IPO broke its $12 offering price and traded below the $11.28 underwriters price. In the first half-hour...
- December 29th, 2016 at 10:18 am

Why Cannabis Investors Prefer Canada

Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during...
- December 26th, 2016 at 1:30 pm